These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 9015400)

  • 1. Vascular effects of loop diuretics.
    Dormans TP; Pickkers P; Russel FG; Smits P
    Cardiovasc Res; 1996 Dec; 32(6):988-97. PubMed ID: 9015400
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vasodilatory action of loop diuretics: a plethysmography study of endothelial function in forearm arteries and dorsal hand veins in hypertensive patients and controls.
    de Berrazueta JR; González JP; de Mier I; Poveda JJ; García-Unzueta MT
    J Cardiovasc Pharmacol; 2007 Feb; 49(2):90-5. PubMed ID: 17312449
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Brain natriuretic peptide enhances renal actions of furosemide and suppresses furosemide-induced aldosterone activation in experimental heart failure.
    Cataliotti A; Boerrigter G; Costello-Boerrigter LC; Schirger JA; Tsuruda T; Heublein DM; Chen HH; Malatino LS; Burnett JC
    Circulation; 2004 Apr; 109(13):1680-5. PubMed ID: 15023890
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Piretanide. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy.
    Clissold SP; Brogden RN
    Drugs; 1985 Jun; 29(6):489-530. PubMed ID: 3891305
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of the loop diuretic torsemide in three dogs with advanced heart failure.
    Oyama MA; Peddle GD; Reynolds CA; Singletary GE
    J Vet Cardiol; 2011 Dec; 13(4):287-92. PubMed ID: 22030290
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of tolvaptan on systemic and renal hemodynamic function in dogs with congestive heart failure.
    Onogawa T; Sakamoto Y; Nakamura S; Nakayama S; Fujiki H; Yamamura Y
    Cardiovasc Drugs Ther; 2011 Dec; 25 Suppl 1():S67-76. PubMed ID: 22120095
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Symptomatic achievements with diuretics in congestive heart failure.
    Mattioli AV; Castellani ET; Casali E; Mattioli G
    Cardiology; 1994; 84 Suppl 2():131-4. PubMed ID: 7954535
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Urocortin 2 inhibits furosemide-induced activation of renin and enhances renal function and diuretic responsiveness in experimental heart failure.
    Rademaker MT; Charles CJ; Nicholls MG; Richards AM
    Circ Heart Fail; 2009 Nov; 2(6):532-40. PubMed ID: 19919977
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Diuretics in the treatment of chronic heart failure].
    Solal AC; Gourgon R
    Presse Med; 1990 Sep; 19(30):1391-3. PubMed ID: 2146619
    [No Abstract]   [Full Text] [Related]  

  • 10. Acute heart failure with dyspnoea: initial treatment. Furosemide and trinitrine, despite the lack of a proven survival benefit.
    Prescrire Int; 2011 Jun; 20(117):156-60. PubMed ID: 21678708
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Haemodynamic impact of diuretic therapy in chronic heart failure.
    Silke B
    Cardiology; 1994; 84 Suppl 2():115-23. PubMed ID: 7954533
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diuretics in postinfarction heart failure.
    Taylor SH
    Cardiovasc Drugs Ther; 1993 Dec; 7(6):885-9. PubMed ID: 8011564
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The acute vascular effects of frusemide in heart failure.
    Jhund PS; McMurray JJ; Davie AP
    Br J Clin Pharmacol; 2000 Jul; 50(1):9-13. PubMed ID: 10886111
    [No Abstract]   [Full Text] [Related]  

  • 14. Prognostic Impact of Loop Diuretics in Patients With Chronic Heart Failure　- Effects of Addition of Renin-Angiotensin-Aldosterone System Inhibitors and β-Blockers.
    Miura M; Sugimura K; Sakata Y; Miyata S; Tadaki S; Yamauchi T; Onose T; Tsuji K; Abe R; Oikawa T; Kasahara S; Nochioka K; Takahashi J; Shimokawa H;
    Circ J; 2016 May; 80(6):1396-403. PubMed ID: 27170200
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute and long term effects of loop diuretics in heart failure.
    Krück F
    Drugs; 1991; 41 Suppl 3():60-8. PubMed ID: 1712715
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Furosemide in the long-term management of heart failure: the good, the bad, and the uncertain.
    Weber KT
    J Am Coll Cardiol; 2004 Sep; 44(6):1308-10. PubMed ID: 15364337
    [No Abstract]   [Full Text] [Related]  

  • 17. [Neurohormonal factors in heart failure. II].
    Cosín Aguilar J; Cruz Fernández JM; de Teresa Galván E; Ferreira Montero IJ; López-Sendón J; Soler Soler J; Tamargo Menéndez J
    Rev Esp Cardiol; 1996 May; 49(5):317-27. PubMed ID: 8744385
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Progress in management for heart failure: diuretics].
    Aoyagi T; Hirata Y
    Nihon Rinsho; 1993 May; 51(5):1281-6. PubMed ID: 8331795
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Loop-diuretics anno 1992. Mechanisms of effect and current therapeutic principles].
    Berg KJ
    Tidsskr Nor Laegeforen; 1992 Feb; 112(5):656-8. PubMed ID: 1557735
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A reappraisal of loop diuretic choice in heart failure patients.
    Buggey J; Mentz RJ; Pitt B; Eisenstein EL; Anstrom KJ; Velazquez EJ; O'Connor CM
    Am Heart J; 2015 Mar; 169(3):323-33. PubMed ID: 25728721
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.